1 Division of GI Tract Surgical Oncology, Department of Surgical Sciences, University of Campania Luigi Vanvitelli, School of Medicine, Naples, Italy2 Division of Medical Oncology, F. Magrassi Department of Clinical and Experimental Medicine, School of Medicine, Naples, Italy
Checking for direct PDF access through Ovid
BACKGROUND:The existing scores reflecting the patient’s nutritional and inflammatory status do not include all biomarkers and have been poorly studied in colorectal cancers.OBJECTIVE:The purpose of this study was to assess a new prognostic tool, the Naples prognostic score, comparing it with the prognostic nutritional index, controlling nutritional status score, and systemic inflammation score.DESIGN:This was an analysis of patients undergoing surgery for colorectal cancer.SETTINGS:The study was conducted at a university hospital.PATIENTS:A total of 562 patients who underwent surgery for colorectal cancer in July 2004 through June 2014 and 468 patients undergoing potentially curative surgery were included. MaxStat analysis dichotomized neutrophil:lymphocyte ratio, lymphocyte:monocyte ratio, prognostic nutritional index, and the controlling nutritional status score. The Naples prognostic scores were divided into 3 groups (group 0, 1, and 2). The receiver operating characteristic curve for censored survival data compared the prognostic performance of the scoring systems.MAIN OUTCOME MEASURES:Overall survival and complication rates in all patients, as well as recurrence and disease-free survival rates in radically resected patients, were measured.RESULTS:The Naples prognostic score correlated positively with the other scoring systems (p < 0.001) and worsened with advanced tumor stages (p < 0.001). Patients with the worst Naples prognostic score experienced more postoperative complications (all patients, p = 0.010; radically resected patients, p = 0.026). Compared with group 0, patients in groups 1 and 2 had worse overall (group 1, HR = 2.90; group 2, HR = 8.01; p < 0.001) and disease-free survival rates (group 1, HR = 2.57; group 2, HR = 6.95; p < 0.001). Only the Naples prognostic score was an independent significant predictor of overall (HR = 2.0; p = 0.03) and disease-free survival rates (HR = 2.6; p = 0.01). The receiver operating characteristic curve analysis showed that the Naples prognostic score had the best prognostic performance and discriminatory power for overall (p = 0.02) and disease-free survival (p = 0.04).LIMITATIONS:This is a single-center study, and its validity needs additional external validation.CONCLUSIONS:The Naples prognostic score is a simple tool strongly associated with long-term outcome in patients undergoing surgery for colorectal cancer. See Video Abstract at http://links.lww.com/DCR/A469.